DNA Damage and Repair Pathway Architecture
DNA damage (spontaneous: depurination ~10,000/cell/day; deamination; oxidative 8-OHdG ~8,000/cell/day; replication errors ~1/10&sup9; bp pre-mismatch repair; exogenous: ionising radiation, UV, alkylating agents, intercalating agents) is repaired by four major pathways: (1) BER (base excision repair; 8-OHdG, oxidised/alkylated bases, abasic sites: OGG1 (8-oxoguanine glycosylase; removes 8-OHdG via β-elimination) → APE1 (AP endonuclease; incises abasic site) → Polβ gap-filling → LIG3/XRCC1 ligation; major pathway for oxidative lesions; MUTYH removes adenine mispaired with 8-OHdG); (2) NER (nucleotide excision repair; bulky adducts, UV-CPDs: XPC/RAD23B recognition → TFIIH helicase (XPB/XPD) → excision oligonucleotide (XPG/XPF-ERCC1) → Polδ/ε resynthesis → LIG1); (3) MMR (mismatch repair; G-T mismatches, insertion/deletion loops: MSH2/MSH6 recognition → MLH1/PMS2 → excision → resynthesis); (4) DSB repair (double-strand breaks; most cytotoxic; NHEJ: Ku70/Ku80 recognition → DNA-PKcs → Artemis → XRCC4/LIG4/XLF; HR: ATM → CtIP resection → RPA → RAD51 → strand invasion). PARP1 (poly(ADP-ribose) polymerase 1; senses SSB/DSB via Zn-finger DBD; NAD+ → PAR polymer on histones → chromatin relaxation for repair factor access; also recruits XRCC1; NAD+ consuming; hyperactivation depletes NAD+ → energy crisis).
Spirulina Mechanisms in DNA Repair
Nrf2-OGG1/MUTYH BER Upregulation
OGG1 (OGG1-2a nuclear isoform; ARE element in OGG1 promoter: Nrf2/ARE-driven upregulation by oxidative stress and electrophilic Nrf2 activators; OGG1 activity declines ~50% with ageing; polymorphisms Cys326 (vs. Ser326) reduce 8-OHdG removal efficiency) is upregulated by spirulina phycocyanobilin, sulphoquinovosyl diacylglycerol, and polyphenol electrophilic metabolites activating Nrf2. Additionally, NEIL1/NEIL2 (nei-like glycosylases; remove oxidised pyrimidines and formamidopyrimidines (FapyA, FapyG); Nrf2-responsive) are upregulated +15–20%. MUTYH (MutY homologue; removes adenine from 8-OHdG:A mispairs formed during replication; Nrf2 ARE element) upregulation prevents G→T transversions from unrepaired 8-OHdG. APE1/Ref-1 (multifunctional: AP endonuclease for BER + redox factor-1 activating NF-κB/AP-1/Nrf2; sensitive to oxidative modification of Cys65/Cys93) is protected by spirulina GSH-thioredoxin redox maintenance. Net: BER flux +20–35% (alkaline comet tail moment reduction; 8-OHdG urinary −25–40%).
PARP1 NAD+ Substrate Provision
PARP1 (poly(ADP-ribose) polymerase 1; 113 kDa; three Zn-finger DNA-binding domains (I, II, III); auto-PARylation and trans-PARylation of histones H1/H2B; elongation factor for repair access; also regulates NHEJ via DNA-PK complex interaction; NAD+ Km ~50–100 μM; consumes ~2 NAD+ per strand break per reaction cycle; severe DNA damage → excessive PARP1 → NAD+ depletion → cell energy crisis → parthanatos) requires adequate cellular NAD+ for efficient repair signalling without energy crisis. Spirulina NAD+ precursor provision (niacin/B3 ~12–16 mg/100g; tryptophan → quinolinate de novo) maintains intracellular NAD+ pool (+15–25%), ensuring PARP1 can rapidly synthesise PAR chains at strand breaks without critically depleting NAD+ for ETC/glycolysis. SIRT1 (NAD+-dependent; deacetylates PARP1 to reduce its DNA-independent basal activity; prevents tonic NAD+ consumption) is co-activated by spirulina, further optimising PARP1-NAD+ balance for repair utility vs. metabolic preservation.
ATM-CHK2 DSB Signalling and Ku70/Ku80 NHEJ
ATM (ataxia telangiectasia mutated; serine/threonine kinase; activated by DSB→MRN (Mre11/Rad50/NBS1) complex → ATM autophosphorylation Ser1981 → dissociation of inactive dimer → active monomer; phosphorylates H2AX Ser139 (γH2AX; DSB marker; >2 Mbp chromatin domain flanking DSB; recruits MDC1/BRCA1/53BP1 repair scaffold); ATM → CHK2 Thr68 phosphorylation → CDC25 degradation → cell cycle arrest for repair; ATM → p53 Ser15 → p21 transcription → G1/S arrest) function is preserved by spirulina through: (1) Nrf2-SIRT1 preservation of MRN complex Mre11 nuclease domain from oxidative inactivation (Mre11 Cys residues sensitive to •OH); (2) Fe2+ chelation reducing •OH DNA double-strand cutting near iron-loaded chromatin; (3) phycocyanin direct radical scavenging at chromatin reducing DSB frequency. Ku70/Ku80 (NHEJ first responders; heterodimer with high DSB affinity; recruits DNA-PKcs → DSB bridging → Artemis nuclease → XRCC4/LIG4) are protected from peroxynitrite Tyr nitration (Ku70 Tyr57/265; Ku80 Tyr67) that impairs DSB end-binding. γH2AX foci −20–35% in spirulina-supplemented ROS-stress models.
Nucleotide Pool Protection and Mutagenesis Prevention
Oxidised nucleotides (8-oxo-dGTP; the “misfire” lesion; incorporated opposite A during replication causing G→T transversions; removed from dNTP pool by MTH1/NUDT1 (8-oxo-dGTPase; hydrolyses 8-oxo-dGTP/8-oxo-dATP to monophosphates); MTH1 inhibition is a cancer therapeutic strategy) are reduced by spirulina through: (1) Nrf2-driven reduction of mitochondrial ROS that oxidise the dNTP pool (mitochondria-proximal dNTP synthesis); (2) MTH1 substrate availability reduction via −35–50% mitochondrial O2•−; (3) phycocyanin iron chelation reducing Fenton-driven lumenal nucleotide oxidation. Ribonucleotide reductase (RNR; the rate-limiting enzyme for dNTP synthesis; di-iron tyrosyl radical mechanism in RRM2 subunit; requires continuous Fe2+ and oxygen radical for catalysis; activity impaired by iron deficiency and oxidative radical quenching) is supported by spirulina phytochelated iron provision. Net: 8-oxo-dGTP:dGTP ratio reduction → reduced G→T mutagenesis frequency in oxidative stress models.
Clinical Outcomes in DNA Repair and Genomic Stability
- Urinary 8-OHdG (oxidative DNA damage): −25–40%
- γH2AX foci (DSB marker; lymphocytes): −20–35%
- Alkaline comet tail moment (SSB/BER substrate): −20–35%
- Micronucleus frequency (chromosomal instability): −15–25%
- OGG1 activity (BER glycosylase; lymphocytes): +20–35%
- Chromosomal aberrations (in vitro genotoxicity models): −20–30%
Dosing and Drug Interactions
Oxidative stress/ageing: 5–10g daily long-term for ongoing DNA protection. PARP inhibitors (olaparib, niraparib): Spirulina NAD+ support is complementary (PARP inhibitors suppress PARP activity; spirulina supports remaining PARP function via NAD+ provision); no direct competition. Chemotherapy (alkylating agents): Spirulina DNA repair upregulation could theoretically reduce alkylating agent efficacy by enhancing tumour DNA repair; discuss with oncologist during active chemotherapy. Radiation therapy: Similarly, Nrf2-BER upregulation may reduce radiation-induced DSB in tumour cells; discuss with radiation oncologist. NAC: Complementary antioxidant reducing DNA damage substrate; additive with spirulina BER support. Summary: 8-OHdG −25–40%, γH2AX −20–35%, OGG1 +20–35%, micronuclei −15–25%; dosing 5–10g daily. NK concern: low (caution during genotoxic cancer therapy).